02211 UNI HEALTH
- 0.069
- 0.0000.00%
UNI HEALTH News
Chongqing Baiya Sanitary Products (003006.SZ): In the first half of the year, the revenue of the health series products accounted for more than 40% of the sanitary napkins.
On August 12th, Gelonhui reported that Chongqing Baiya Sanitary Products (003006.SZ) has disclosed its investor relations activity record, showing that the company continues to promote product structure upgrade iterations, and over the past two years, resources have focused on a series of large health products represented by probiotics. In the first half of this year, the proportion of revenue from the large health product series has reached more than 40% of the sanitary napkins, and there is still considerable room for growth in the future.
Special treat Bailin (002424.SZ): The main source of revenue is Tibet Jinling and Big Health Company.
On August 7, 2024, ST Baoling (002424.SZ) accepted a specific object survey on "what are the parts included in commerce?" The company responded that commercial revenue is mainly from Tibet Special Treat and Pharmaceutical Commerce. Tibet Special Treat is a sales channel for OTC products and sales of OEM products. Pharmaceutical Commerce mainly sells and distributes pharmaceuticals in the local market of Anshun.
Guotou Securities: The market share of listed pharmacies continues to increase, and the growth potential is expected to lead the industry.
In the context of a slowdown in the industry's growth rate, listed pharmacies are expected to achieve growth rates higher than the industry by virtue of their continuous rapid expansion of stores.
Zhangzhou Pientzehuang Pharmaceutical (600436.SH) plans to participate in the establishment of a 0.2 billion yuan fund with Yuanshan to strengthen its ability to integrate the industry chain.
Zhangzhou Pientzehuang Pharmaceutical (600436.SH) announced that the company plans to participate in the investment of Zhangzhou Yuanshan Dahealth Industry Investment Fund Partnership Enterprise...
Dnake (300884.SZ): In the future, micro high pressure oxygen cabin solutions will mainly be applied in areas such as home health and wellness.
Dnake (300884.SZ) announced on its investor platform on July 31 that in the future, the company's micro-high-pressure oxygen cabin solutions will mainly be used in the fields of home health and health. Please refer to the official announcement published by the company in the designated information disclosure media for the company's business development.
Chongqing Pharscin Pharmaceutical (002907.SZ): currently produces vitamin-based health products through commissioned processing.
Chongqing Pharscin Pharmaceutical (002907.SZ) stated on its investor interaction platform that the company does not currently have relevant production lines. The vitamin-based health products it currently launches are commissioned for processing, including grape seed vitamin E capsules, B group vitamin tablets, calcium vitamin D vitamin K capsules, vitamin C tablets, collagen vitamin C vitamin E tablets, etc. You can purchase them at Huasen Pharmaceutical flagship store on Tmall, Huasen Health flagship store on Taobao, Huasen Nutrition Dietary Specialty Store on Douyin store, Huasen Pharmacy flagship store on Pinduoduo, and Huasen Medical Flagship Store on jd.com, and follow WeChat public account "Huasen Corporation".
China Securities Co., Ltd.'s healthcare strategy for the second half of the year: prescription drugs continue to climb, and the traditional Chinese medicine sector is expected to improve its growth rate.
Keep the faith and wait for the opportunity.
Sharetronic Data Technology (300857.SZ): The addition of health products and video cloud platform has led the increase in gross margin within the country.
Sharetronic Data Technology (300857.SZ) stated on the investor interaction platform on July 11 that in 2023, the company increased its investment in research and development. With the increase in the company's self-developed product lines, such as the new health products line and the video cloud platform, it led to the first increase in the gross margin rate in the domestic market. The company will continue to focus on overseas markets, develop customers, improve bargaining power, and promote the improvement of the overseas gross margin rate of the company's products.
Uni health international (02211) issued 133.5 million shares based on the subscription agreement.
Uni Health (02211) announced that, according to four subscription agreements dated June 12, 2024, a total of 133.5 million shares will be issued and distributed under general authorization.
Chongqing Pharscin Pharmaceutical (002907.SZ) has launched the 'Yanpin Senhuo' series of health products.
On June 26th, Gelunhui investors asked Chongqing Pharscin Pharmaceutical (002907.SZ) on the investor interaction platform, "Does the company produce vitamins?" The company replied that it has launched the "Yanpin Senhuo" healthy living series of products, which includes a variety of vitamin-based health products such as grape seed vitamin E capsules, B vitamins, calcium vitamin D vitamin K capsules, vitamin C tablets, and collagen vitamin C vitamin E tablets.
Grace Life-tech (02112.HK) has signed a "Strategic Cooperation Framework Agreement" with Bingcao Gangmu to strengthen their cooperation in the field of the great health industry (plant formation layer stem cell platform technology project).
On June 21, Gelonhui announced that Grace Life-Tech (02112.HK), through its wholly-owned subsidiary Shenzhen Ende Times Life Technology Co., Ltd. (hereinafter referred to as "Shenzhen Grace"), signed a Strategic Cooperation Framework Agreement (hereinafter referred to as the "Agreement") with Tianjin Bingcaogangmu Biotechnology Co., Ltd. (hereinafter referred to as "Bingcaogangmu") on this announcement date. The aim of the Agreement is to strengthen cooperation between the two parties in the field of health industry (plant formation layer stem cell platform technology project), promote the development of various businesses of both parties, achieve equal benefits, resource sharing, complementary advantages and win-win development. Bingcaogangmu is a company specialized in
China Pacific Insurance has opened its 15th retirement community in Suzhou, focusing on the needs of nursing and rehabilitation. The strategic development of health industry is deepening.
On June 13, Taibao Pension Investment Company, a subsidiary of China Taibao, signed a tripartite project cooperation agreement with the Taihu New Town Wuzhong Management Committee and Hangzhou Urban Construction Group, marking the official landing of the 15th Taibao Pension Community Project in Suzhou. Taibao Homeland Suzhou International Nursing Community will give full play to the resource advantages of important cities in the national historical and cultural city, the Shanghai metropolitan area, and the Suxi Changdu metropolitan area, focusing on long-term vitality, nursing and rehabilitation customers, taking into account the residential needs of some migratory birds, and creating a boutique urban CCRC pension community to provide more service options for customers with high-quality pension needs in the Yangtze River Delta. Highlight the characteristics of “integrated medical care” and create
Universal Health International to Raise Over HK$10.0 Million via Share Subscriptions
Uni Health (02211.HK) plans to distribute a total of 133.5 million shares and raise HKD 10.2 million in net proceeds.
On June 12, Geelong announced that Uni Health International (02211.HK) had entered into a subscription agreement with the company (as the issuer) and the subscriber had conditionally agreed to subscribe and the company had conditionally agreed to issue and allot a total of 133,509,926 subscription shares for a total cash consideration of approximately HKD 10.7 million. The subscription shares subscribed under the subscription agreement represent approximately 20.00% of the existing issued share capital of the Company as of the date of announcement, and the subscription price per subscription share is HKD 0.08 on June 12, 2024 (i.e., the subscription agreement.
Express News | Universal Health International Group - to Allot and Issue 133.5 Mln Subscription Shares at HK$0.08 per Share
Ruiong Gene (688217.SH): Shareholder Zhejiang Health plans to reduce its shareholding by no more than 2%.
On June 4th, Gelunhui reported that Ruiong Gene (688217.SH) announced that due to its shareholder's own capital needs, Zhejiang Dajiankang intends to reduce its total holdings of the company's shares through centralized bidding and bulk transactions by no more than 1,117,116 shares, accounting for no more than 2% of the total share capital of the company. Zhejiang Dajiankang intends to reduce the number of company shares it holds through centralized bidding by no more than 558,558 shares, accounting for no more than 1% of the total share capital of the company, and the total number of shares to be sold within any consecutive 90 calendar days shall not exceed 1% of the company's total number of shares; intends to carry out bulk transactions.
Warner Pharmaceuticals (688799.SH) plans to explore investment opportunities in the medical and health sector in markets such as China and Southeast Asia through funds
Warner Pharmaceuticals (688799.SH) announced that the company plans to invest no more than RMB 40 million to pledge Hainan Heyi...
China Development Co., Ltd. (600538.SH): Vigorously expand the field of general health and judicial IVD
Gelonghui, May 15, 丨 Guofa Co., Ltd. (600538.SH) said at the performance briefing that the stock price is affected by multiple factors such as macroeconomics, industry policies, and market environment. The company's management closely monitors the company's stock price fluctuations and attaches great importance to market value management. The company will focus on its main business, continue to do a good job in business management, consolidate the foundation for development, and continuously enhance the company's internal value. At the same time, we will continue to focus on the company's long-term development goals, innovative ideas, and focus on health development strategies, take high-tech development as the lead, use existing industries as the foundation, biotechnology as the core, and vigorously expand the field of health and judicial IVD, especially the roots
Bepsis (301080.SZ): The company focuses on life science and health, providing biological reagents and technical services such as recombinant proteins, antibodies, enzymes, etc.
On May 13, GLONGHUI (301080.SZ) said on the investor interactive platform that synthetic biology is a technical field involving various disciplines such as genetic engineering, molecular biology, and fermentation engineering, and has shown huge application potential in various fields such as chemicals, energy, and healthcare. The company focuses on the fields of life science and health, providing biological reagents and technical services such as recombinant proteins, antibodies, enzymes, etc., while actively following the development of cutting-edge technology and exploring the application of biological reagent products in the medical and health care field.
Black Sesame (000716.SZ): At this stage, the company is focusing on the health food production and operation business
Gelonghui, May 8 | Black Sesame (000716.SZ) said on the investor interactive platform that the company is currently focusing on the health food production and operation business.
Analysis
Price Target
No Data
